Latest Europe News

International Graphite Limited (ASX: IG6) and ALKEEMIA have achieved graphite purification exceeding 99.9% total graphitic carbon across diverse concentrate samples, reinforcing their joint venture plans to build a major processing hub in Italy.

Little Green Pharma Ltd (ASX:LGP) has secured overwhelming shareholder approval from Cannatrek Ltd for its proposed acquisition scheme, advancing the transaction toward Federal Court approval and implementation by early May 2026.

Ainsworth Game Technology Limited has released its Target’s Statement recommending shareholders accept an unconditional proportional off-market takeover bid by Mr Kjerulf David Hastings Ainsworth at $1.30 per share, representing a premium to recent trading prices.

IODM Limited has renewed its commercial agreement with Convera for the UK higher education sector, increasing its revenue share and shifting to a non-exclusive arrangement that broadens its market opportunities.

Apollo Minerals Limited has validated significant historical tungsten intercepts up to 5.3% WO3 in unmined areas of its Couflens Project in France, highlighting exploration potential around the Veronique Zone and advancing preparations for further drilling.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals has broadened availability of DAYBUE STIX, a new FDA-approved powder formulation of trofinetide for Rett syndrome, in the US. Early caregiver feedback and expert consensus highlight its potential role in personalised patient care.

Aldoro Resources Ltd (ASX: ARN) has announced assay results from drill hole DD005G at its Kameelburg project in Namibia, confirming 537 metres of continuous rare earth elements, strontium, and niobium mineralisation across the entire carbonatite system including the previously untested central core.

The Savana US Small Caps Active ETF (ASX:SVNP) posted a 1.28% gain in March 2026, outperforming the S&P 600 benchmark by 1.46%, supported by USD/AUD currency appreciation despite a modest portfolio decline amid geopolitical tensions.

Orbital UAV has entered the Middle East market with a USD 1.1 million order from a UAE sovereign government for its 50HFE propulsion systems and signed a long-term distribution agreement to expand its UAV propulsion presence.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

European Resources Limited has announced promising metallurgical beneficiation outcomes from its Korsnäs rare earths project in Finland, advancing the development of an integrated processing flowsheet under the EU-funded REMHub program.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.